South America Respiratory Inhalers Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)
The South America respiratory inhalers market is expected to grow from US$ 2,784.32 million in 2022 to US$ 3,636.45 million by 2028. It is estimated to register a CAGR of 4.6% from 2022 to 2028.
Increasing Adoption of Smart Inhalers Technology to Provide Growth Opportunities to South America Respiratory Inhalers Market
Smart inhalers aim to help people suffering from asthma ensure they take their medication as prescribed by recording the timing and dosage on their smartphones. The data collected can be used by a clinician to verify that the prescribed treatment is working, personalize asthma reviews to focus on the root causes of worsening symptoms, and provide early warning systems that inform when to visit a clinic. This technology could shift from one-size-fits-all asthma screening and lead to fewer routine appointments, which could ease pressure on the National Health Service (NHS). Adults and the geriatric population struggle to take the same puffs due to uneven breathing as the muscles that support breathing and the diaphragm weaken with age, preventing them from inhaling or exhaling enough air. Smart inhalers can benefit them., Smart inhalers that are equipped with sensors can be connected to conventional inhalers and help to keep track of when the medication is taken. Being Bluetooth-enabled, they can also be remotely paired with a computer or smart device, such as a phone or tablet, to transfer data from the smart inhaler automatically. Therefore, the above-mentioned applications of smart inhalers and their growing adoption are expected to provide growth opportunities to the respiratory inhalers market in the coming years.
South America Respiratory Inhalers Market Overview
The South America respiratory inhalers market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the South America respiratory inhalers market in 2022. Brazil is the fifth-largest country globally, both by area and by population. The healthcare facilities and services are better in the country compared to the other countries in the region. It has been experiencing the fastest demographic aging worldwide. In 2020, the geriatric population accounted for 30.1 million, ~14.3% of the total population. Further, as per the Brazil Statistical Institute, people aged 65 and over are expected to reach 36% of the total population by 2050. Aging increases vulnerability to various chronic diseases. For example, lung disorders, including idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease, have become more common among older people. As the geriatric population in Brazil grows, it leads to an increased incidence of various health illnesses, such as respiratory diseases, leading to increased demand for respiratory inhalers. All these factors are likely to drive the adoption of respiratory inhalers, eventually offering opportunities to the Brazil respiratory inhalers market.
South America Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
South America Respiratory Inhalers Market Segmentation
The South America respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the South America respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the South America respiratory inhalers market in 2022.
Based on technology, the South America respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the South America respiratory inhalers market in 2022.
Based on disease indication, the South America respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the South America respiratory inhalers market in 2022.
Based on country, the South America respiratory inhalers market has been categorized into Brazil, Argentina, and the Rest of South America. Brazil dominated the South America respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the South America respiratory inhalers market.
Increasing Adoption of Smart Inhalers Technology to Provide Growth Opportunities to South America Respiratory Inhalers Market
Smart inhalers aim to help people suffering from asthma ensure they take their medication as prescribed by recording the timing and dosage on their smartphones. The data collected can be used by a clinician to verify that the prescribed treatment is working, personalize asthma reviews to focus on the root causes of worsening symptoms, and provide early warning systems that inform when to visit a clinic. This technology could shift from one-size-fits-all asthma screening and lead to fewer routine appointments, which could ease pressure on the National Health Service (NHS). Adults and the geriatric population struggle to take the same puffs due to uneven breathing as the muscles that support breathing and the diaphragm weaken with age, preventing them from inhaling or exhaling enough air. Smart inhalers can benefit them., Smart inhalers that are equipped with sensors can be connected to conventional inhalers and help to keep track of when the medication is taken. Being Bluetooth-enabled, they can also be remotely paired with a computer or smart device, such as a phone or tablet, to transfer data from the smart inhaler automatically. Therefore, the above-mentioned applications of smart inhalers and their growing adoption are expected to provide growth opportunities to the respiratory inhalers market in the coming years.
South America Respiratory Inhalers Market Overview
The South America respiratory inhalers market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the South America respiratory inhalers market in 2022. Brazil is the fifth-largest country globally, both by area and by population. The healthcare facilities and services are better in the country compared to the other countries in the region. It has been experiencing the fastest demographic aging worldwide. In 2020, the geriatric population accounted for 30.1 million, ~14.3% of the total population. Further, as per the Brazil Statistical Institute, people aged 65 and over are expected to reach 36% of the total population by 2050. Aging increases vulnerability to various chronic diseases. For example, lung disorders, including idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease, have become more common among older people. As the geriatric population in Brazil grows, it leads to an increased incidence of various health illnesses, such as respiratory diseases, leading to increased demand for respiratory inhalers. All these factors are likely to drive the adoption of respiratory inhalers, eventually offering opportunities to the Brazil respiratory inhalers market.
South America Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
South America Respiratory Inhalers Market Segmentation
The South America respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the South America respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the South America respiratory inhalers market in 2022.
Based on technology, the South America respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the South America respiratory inhalers market in 2022.
Based on disease indication, the South America respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the South America respiratory inhalers market in 2022.
Based on country, the South America respiratory inhalers market has been categorized into Brazil, Argentina, and the Rest of South America. Brazil dominated the South America respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the South America respiratory inhalers market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South America Respiratory Inhalers Market – by Product Type
1.3.2 South America Respiratory Inhalers Market – by Technology
1.3.3 South America Respiratory Inhalers Market – by Disease Indication
1.3.4 South America Respiratory Inhalers Market – by Country
2. SOUTH AMERICA RESPIRATORY INHALERS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH AMERICA RESPIRATORY INHALERS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 South America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH AMERICA RESPIRATORY INHALERS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. RESPIRATORY INHALERS MARKET – SOUTH AMERICA ANALYSIS
6.1 South America Respiratory Inhalers Market Revenue Forecast and Analysis
7. SOUTH AMERICA RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT TYPE
7.1 Overview
7.2 South America Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. SOUTH AMERICA RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY TECHNOLOGY
8.1 Overview
8.2 South America Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. SOUTH AMERICA RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY DISEASE INDICATION
9.1 Overview
9.2 South America Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. SOUTH AMERICA RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 South America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 Brazil: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.1.3.2 Brazil: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.1.1.3.3 Brazil: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.1.4 Brazil: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.1.5 Brazil: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.2 Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 Argentina: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.2.3.2 Argentina: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.1.2.3.3 Argentina: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.2.4 Argentina: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.2.5 Argentina: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.3 Rest of South America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of South America: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 Rest of South America: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.3.3.2 Rest of South America: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.1.3.3.3 Rest of South America: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.3.4 Rest of South America: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.3.5 Rest of South America: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South America Respiratory Inhalers Market – by Product Type
1.3.2 South America Respiratory Inhalers Market – by Technology
1.3.3 South America Respiratory Inhalers Market – by Disease Indication
1.3.4 South America Respiratory Inhalers Market – by Country
2. SOUTH AMERICA RESPIRATORY INHALERS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH AMERICA RESPIRATORY INHALERS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 South America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH AMERICA RESPIRATORY INHALERS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. RESPIRATORY INHALERS MARKET – SOUTH AMERICA ANALYSIS
6.1 South America Respiratory Inhalers Market Revenue Forecast and Analysis
7. SOUTH AMERICA RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT TYPE
7.1 Overview
7.2 South America Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. SOUTH AMERICA RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY TECHNOLOGY
8.1 Overview
8.2 South America Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. SOUTH AMERICA RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY DISEASE INDICATION
9.1 Overview
9.2 South America Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. SOUTH AMERICA RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 South America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 Brazil: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.1.3.2 Brazil: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.1.1.3.3 Brazil: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.1.4 Brazil: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.1.5 Brazil: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.2 Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 Argentina: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.2.3.2 Argentina: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.1.2.3.3 Argentina: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.2.4 Argentina: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.2.5 Argentina: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.3 Rest of South America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of South America: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 Rest of South America: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.3.3.2 Rest of South America: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.1.3.3.3 Rest of South America: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.3.4 Rest of South America: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.3.5 Rest of South America: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South America Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of South America Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of South America Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of South America Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of South America Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of South America Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Recent Inorganic Growth Strategies
Table 20. Recent Organic Growth Strategies
Table 21. Glossary of Terms
Table 1. Brazil Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South America Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of South America Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of South America Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of South America Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of South America Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of South America Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Recent Inorganic Growth Strategies
Table 20. Recent Organic Growth Strategies
Table 21. Glossary of Terms
LIST OF FIGURES
Figure 1. South America Respiratory Inhalers Market Segmentation
Figure 2. South America Respiratory Inhalers Market, by Country
Figure 3. South America Respiratory Inhalers Market Overview
Figure 4. South America Respiratory Inhalers Market, By Product
Figure 5. South America Respiratory Inhalers Market, By Country
Figure 6. South America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South America Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. South America Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. South America Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. South America Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. South America Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. South America: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. South America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
Figure 31. Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of South America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 1. South America Respiratory Inhalers Market Segmentation
Figure 2. South America Respiratory Inhalers Market, by Country
Figure 3. South America Respiratory Inhalers Market Overview
Figure 4. South America Respiratory Inhalers Market, By Product
Figure 5. South America Respiratory Inhalers Market, By Country
Figure 6. South America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South America Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. South America Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. South America Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. South America Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. South America Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: South America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. South America: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. South America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
Figure 31. Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of South America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
